サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1362997

子宮鏡検査手順の市場規模、シェア、動向分析レポート：手順別、最終用途別、地域別、セグメント予測、2023年～2030年

Hysteroscopy Procedures Market Size, Share & Trends Analysis Report By Procedure (CPT Code 58558, CPT Code 58353), By End-use (Ambulatory Surgical Centers, Hospitals, Clinics), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 125 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.11円
子宮鏡検査手順の市場規模、シェア、動向分析レポート：手順別、最終用途別、地域別、セグメント予測、2023年～2030年
出版日: 2023年09月13日
発行: Grand View Research
ページ情報: 英文 125 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

子宮鏡検査手順市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の子宮鏡検査手順市場規模は、2023年から2030年にかけて7.4％のCAGRで成長し、2030年までに74億米ドルに達すると予測されています。

婦人科疾患の有病率の急増、技術の進歩、低侵襲手術の採用増加、有利な償還政策が市場の主な促進要因です。さらに、COVID-19パンデミックは市場に大きな影響を与えています。

パンデミックは企業の新製品・先端製品の開発・商品化能力に影響を及ぼしています。ほぼすべての企業が、パンデミックによる手術件数の減少の影響を受けています。さらに、限られた数の役所の制限と機能により、製品の臨床試験が遅れることが予想され、その結果、企業による製品発売が遅れることが予想されます。

子宮筋腫の有病率の増加は、市場を牽引する重要な要因です。例えば、Dove Press Ltd.に掲載された調査記事によると、子宮筋腫の有病率は年齢層によって5.4%から23.6%に及びます。さらに、子宮筋腫は25％の女性に深刻な問題を引き起こす可能性があります。子宮鏡検査は、出血過多、ひどい腹痛、反復流産、妊娠困難などの異常を診断するために行われます。したがって、このような大規模な患者予備軍の存在は、子宮鏡検査手順の需要増加につながります。

子宮鏡検査手順市場レポート・ハイライト

  • 病院の最終用途セグメントは、2022年に52.5％以上の最大の収益シェアを占めました。このセグメントの成長は、婦人科疾患の症例数が多いことによります。
  • アジア太平洋は、APAC地域における高齢化人口の増加と相まって、大規模な患者予備軍が存在するため、予測期間で最も速いCAGRで成長すると期待されています。
  • 子宮鏡検査をオフィス診療に組み込むことは、主要市場プレーヤーに有利な機会を提供します。いくつかの企業がオフィス子宮鏡検査と関連機器を発売しています。
  • 例えば、最近Meditrina Inc.が2020年3月に発売したAveta System（オフィス子宮鏡検査）は、子宮内病理のためのオールインワン組織除去ソリューションで、広角HD子宮鏡検査を提供します。
  • さらに、オフィスでの子宮鏡検査は、効率的かつ臨床的に有益であり、患者中心のアプローチを提供するため、従来の子宮鏡検査手順よりも有益です。
  • また、子宮内避妊具を取り出すためのシンプルで迅速なツールでもあります。したがって、医師は子宮鏡検査に機器に投資し、オフィス内アプローチを採用することを検討すると思われます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 子宮鏡検査手順の市場変数、動向および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • 子宮鏡検査手順市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析
    • 主要取引と戦略的提携の分析
    • 市場参入戦略

第4章 子宮鏡検査手順市場：手順の推定・動向分析

  • 子宮鏡検査手順市場：重要なポイント
  • 子宮鏡検査手順市場：動向と市場シェア分析、2022年および2030年
  • CPTコード 58555
  • CPTコード 58558
  • CPTコード 58562
  • CPTコード 58340
  • CPTコード 58563
  • CPTコード 58565
  • CPTコード 58353
  • CPTコード 58561、74740など（その他）

第5章 子宮鏡検査手順市場：最終使用推定・動向分析

  • 子宮鏡検査手順市場：重要なポイント
  • 子宮鏡検査手順市場：動向と市場シェア分析、2022年および2030年
  • 病院
  • クリニック
  • 外来手術センター

第6章 子宮鏡検査手順市場：地域推定・動向分析

  • 地域別の展望
  • 地域別の子宮鏡検査手順市場：重要なポイント
  • 北米
    • 市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • Medtronic
    • Stryker Corp.
    • Hologic, Inc.
    • KARL STORZZ SE & CO. Kg
    • Medical Devices Business Services, Inc (Ethicon, Inc)
    • Olympus Corp.
    • Delmont Imaging
    • B. Braun Melsungen AG
    • Richard Wolf GmbH
    • CooperCompanies
    • Maxer Endoscopy GmbH
    • Boston Scientific Corp.
    • MedGyn Products, Inc.
    • Lina Medical APS
    • Luminelle
    • Meditrina, Inc. (Aveta)
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America hysteroscopy procedures market, by procedures, 2017 - 2030 (USD Million)
  • Table 3 North America hysteroscopy procedures market, by end-use, 2017 - 2030 (USD Million)
  • Table 4 North America hysteroscopy procedures market, by region (USD Million) 2017 to 2030
  • Table 5 U.S. hysteroscopy procedures market, by procedures, 2017 - 2030 (USD Million)
  • Table 6 U.S. hysteroscopy procedures market, by end-use, 2017 - 2030 (USD Million)
  • Table 7 Canada hysteroscopy procedures market, by procedures, 2017 - 2030 (USD Million)
  • Table 8 Canada hysteroscopy procedures market, by end-use, 2017 - 2030 (USD Million)
  • Table 9 Europe hysteroscopy procedures market, by procedures, 2017 - 2030 (USD Million)
  • Table 10 Europe hysteroscopy procedures market, by end-use, 2017 - 2030 (USD Million)
  • Table 11 Europe hysteroscopy procedures market, by region (USD Million) 2017 to 2030
  • Table 12 Germany hysteroscopy procedures market, by procedures, 2017 - 2030 (USD Million)
  • Table 13 Germany hysteroscopy procedures market, by end-use, 2017 - 2030 (USD Million)
  • Table 14 UK hysteroscopy procedures market, by procedures, 2017 - 2030 (USD Million)
  • Table 15 UK hysteroscopy procedures market, by end-use, 2017 - 2030 (USD Million)
  • Table 16 France hysteroscopy procedures market, by procedures, 2017 - 2030 (USD Million)
  • Table 17 France hysteroscopy procedures market, by end-use, 2017 - 2030 (USD Million)
  • Table 18 Asia Pacific hysteroscopy procedures market, by procedures, 2017 - 2030 (USD Million)
  • Table 19 Asia Pacific hysteroscopy procedures market, by end-use, 2017 - 2030 (USD Million)
  • Table 20 Asia Pacific hysteroscopy procedures market, by region (USD Million) 2017 to 2030
  • Table 21 China hysteroscopy procedures market, by procedures, 2017 - 2030 (USD Million)
  • Table 22 China hysteroscopy procedures market, by end-use, 2017 - 2030 (USD Million)
  • Table 23 Japan hysteroscopy procedures market, by procedures, 2017 - 2030 (USD Million)
  • Table 24 Japan hysteroscopy procedures market, by end-use, 2017 - 2030 (USD Million)
  • Table 25 India hysteroscopy procedures market, by procedures, 2017 - 2030 (USD Million)
  • Table 26 India hysteroscopy procedures market, by end-use, 2017 - 2030 (USD Million)
  • Table 27 Australia hysteroscopy procedures market, by procedures, 2017 - 2030 (USD Million)
  • Table 28 Australia hysteroscopy procedures market, by end-use, 2017 - 2030 (USD Million)
  • Table 29 South Korea hysteroscopy procedures market, by procedures, 2017 - 2030 (USD Million)
  • Table 30 South Korea hysteroscopy procedures market, by end-use, 2017 - 2030 (USD Million)
  • Table 31 Latin America hysteroscopy procedures market, by procedures, 2017 - 2030 (USD Million)
  • Table 32 Latin America hysteroscopy procedures market, by end-use, 2017 - 2030 (USD Million)
  • Table 33 Latin America hysteroscopy procedures market, by region (USD Million) 2017 to 2030
  • Table 34 Brazil hysteroscopy procedures market, by procedures, 2017 - 2030 (USD Million)
  • Table 35 Brazil hysteroscopy procedures market, by end-use, 2017 - 2030 (USD Million)
  • Table 36 Mexico hysteroscopy procedures market, by procedures, 2017 - 2030 (USD Million)
  • Table 37 Mexico hysteroscopy procedures market, by end-use, 2017 - 2030 (USD Million)
  • Table 38 Middle East and Africa hysteroscopy procedures market, by procedures, 2017 - 2030 (USD Million)
  • Table 39 Middle East and Africa hysteroscopy procedures market, by end-use, 2017 - 2030 (USD Million)
  • Table 40 Middle East and Africa hysteroscopy procedures market, by region (USD Million) 2017 to 2030
  • Table 41 South Africa hysteroscopy procedures market, by procedures, 2017 - 2030 (USD Million)
  • Table 42 South Africa hysteroscopy procedures market, by end-use, 2017 - 2030 (USD Million)
  • Table 43 Saudi Arabia hysteroscopy procedures market, by procedures, 2017 - 2030 (USD Million)
  • Table 44 Saudi Arabia hysteroscopy procedures market, by end-use, 2017 - 2030 (USD Million)
  • Table 45 UAE hysteroscopy procedures market, by procedures, 2017 - 2030 (USD Million)
  • Table 46 UAE hysteroscopy procedures market, by end-use, 2017 - 2030 (USD Million)

List of Figure

Fig. 1 Market research process

Fig. 2 Data triangulation techniques

Fig. 3 Primary research pattern

Fig. 4 Market research approaches

Fig. 5 Value-chain-based sizing & forecasting

Fig. 6 QFD modeling for market share assessment

Fig. 7 Market formulation & validation

Fig. 8 Hysteroscopy procedures market: Market outlook

Fig. 9 Hysteroscopy procedures market: Competitive insights

Fig. 10 Parent market outlook

Fig. 11 Related/ancillary market outlook

Fig. 12 Penetration and growth prospect mapping

Fig. 13 Industry value chain analysis

Fig. 14 Hysteroscopy procedures market driver impact

Fig. 15 Hysteroscopy procedures market restraint impact

Fig. 16 Hysteroscopy procedures market strategic initiatives analysis

Fig. 17 Hysteroscopy procedures market: Procedures movement analysis

Fig. 18 Hysteroscopy procedures market: Procedures outlook and key takeaways

Fig. 19 CPT code 58555 market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 20 CPT code 58558 market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 21 CPT code 58562 market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 22 CPT code 58540 market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 23 CPT code 58563 market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 24 CPT code 58565 market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 25 CPT code 58353 market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 26 CPT code 58561,74740 and more (others) market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 27 CPT code 58555 market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 28 Hysteroscopy procedures market: End-use movement analysis

Fig. 29 Hysteroscopy procedures market: End-use outlook and key takeaways

Fig. 30 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 31 Clinics market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 32 Ambulatory surgical centers market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 33 Global hysteroscopy procedures market: Regional movement analysis

Fig. 34 Global hysteroscopy procedures market: Regional outlook and key takeaways

Fig. 35 North America market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 36 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 37 Canada market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 38 Europe market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 39 UK market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 40 Germany market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 41 France market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 42 Italy market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 43 Spain market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 44 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 45 Norway market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 46 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 47 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 48 Japan market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 49 China market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 50 India market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 51 Australia market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 52 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 53 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 54 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 55 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 56 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 57 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 58 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 59 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 60 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 61 UAE market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 62 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

目次
Product Code: GVR-4-68039-506-6

Hysteroscopy Procedures Market Growth & Trends:

The global hysteroscopy procedures market size is expected to reach USD 7.4 billion by 2030, registering a CAGR of 7.4% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Surge in prevalence of gynecological disorders, technological advancements, increasing adoption of minimally invasive surgeries, and favorable reimbursement policies are the key driving factors for the market. In addition, the impact of the COVID-19 pandemic has been significant on the market.

The pandemic has affected companies' ability to develop and commercialize new & advanced products. Almost all companies are affected by reduced procedure volumes due to the pandemic, as all hospital resources are being diverted to fight the disease. Furthermore, the restrictions and functioning of a limited number of government offices are expected to delay clinical trials of products, which is expected to result in delayed product launches by companies.

The increasing prevalence of uterine fibroids is a key factor driving the market. For instance, as per the research article published in Dove Press Ltd., the prevalence of uterine fibroid disease ranges from 5.4% to 23.6%, depending upon the age group. Moreover, uterine fibroids can cause serious problems in 25% of women. Hysteroscopy is used to diagnose abnormalities, such as excessive bleeding, severe stomach cramps, recurrent miscarriages, or difficulties in conceiving. Thus, the presence of such a large patient pool leads to increased demand for hysteroscopy procedures.

Hysteroscopy Procedures Market Report Highlights:

  • The hospitals end-use segment held the largest revenue share of over 52.5% in 2022. The segment growth is credited to the high number of cases of gynecological disorders
  • Asia Pacific is expected to witness the fastest CAGR over the forecast period due to the presence of a large patient pool coupled with the rising aging population in the APAC region
  • Integrating hysteroscopy into office practice will provide a lucrative opportunity for key market players. Several players have launched office hysteroscopy and associated devices
  • For instance, Aveta System (office hysteroscopy), recently launched by Meditrina Inc. in March 2020, is an all-in-one tissue removal solution for intrauterine pathology, which offers wide-angle HD hysteroscopy
  • Furthermore, in-office hysteroscopy is beneficial over traditional hysteroscopy procedures as it is efficient & clinically beneficial and offers a patient-centric approach
  • It is also a simple and quick tool for retrieving intrauterine devices. Thus, physicians will consider investing in equipment and adopting an in-office approach for hysteroscopy

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Procedures
    • 1.1.2. End-use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Procedures outlook
    • 2.2.2. End-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Hysteroscopy Procedures Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
      • 3.3.1.1. Increasing prevalence of gynecological disorders
      • 3.3.1.2. Rising adoption of minimally invasive surgical procedures
      • 3.3.1.3. Adoption of technologically advanced devices for hysteroscopy procedures
    • 3.3.2. Market restraint analysis
      • 3.3.2.1. High cost of hysteroscopy procedures and systems
      • 3.3.2.2. Concerns associated with product approval and commercialization
  • 3.4. Hysteroscopy Procedures Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape
    • 3.4.3. Major Deals & Strategic Alliances Analysis
    • 3.4.4. Market Entry Strategies

Chapter 4. Hysteroscopy Procedures Market: Procedure Estimates & Trend Analysis

  • 4.1. Hysteroscopy Procedures Market: Key Takeaways
  • 4.2. Hysteroscopy Procedures Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. CPT code 58555
    • 4.3.1. CPT code 58555 market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. CPT code 58558
    • 4.4.1. CPT code 58558 market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. CPT code 58562
    • 4.5.1. CPT code 58562 market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. CPT code 58340
    • 4.6.1. CPT code 58340 market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. CPT code 58563
    • 4.7.1. CPT code 58563 market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.8. CPT code 58565
    • 4.8.1. CPT code 58565 market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.9. CPT code 58353
    • 4.9.1. CPT code 58353 market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.10. CPT code 58561, 74740, and more (Others)
    • 4.10.1. CPT code 58561, 74740, and more (Other) market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Hysteroscopy Procedures Market: End-use Estimates & Trend Analysis

  • 5.1. Hysteroscopy Procedures Market: Key Takeaways
  • 5.2. Hysteroscopy Procedures Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Hospitals
    • 5.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Clinics
    • 5.4.1. Clinics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Ambulatory Surgery Centers
    • 5.5.1. Ambulatory Surgery Centers (ASCs) market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Hysteroscopy Procedures Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Hysteroscopy Procedures Market By Region: Key Takeaway
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Denmark
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. Medtronic
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Stryker Corp.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Hologic, Inc.
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. KARL STORZZ SE & CO. Kg
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Medical Devices Business Services, Inc (Ethicon, Inc)
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Olympus Corp.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Delmont Imaging
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. B. Braun Melsungen AG
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Richard Wolf GmbH
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. CooperCompanies
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. Maxer Endoscopy GmbH
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives
    • 7.2.12. Boston Scientific Corp.
      • 7.2.12.1. Company overview
      • 7.2.12.2. Financial performance
      • 7.2.12.3. Product benchmarking
      • 7.2.12.4. Strategic initiatives
    • 7.2.13. MedGyn Products, Inc.
      • 7.2.13.1. Company overview
      • 7.2.13.2. Financial performance
      • 7.2.13.3. Product benchmarking
      • 7.2.13.4. Strategic initiatives
    • 7.2.14. Lina Medical APS
      • 7.2.14.1. Company overview
      • 7.2.14.2. Financial performance
      • 7.2.14.3. Product benchmarking
      • 7.2.14.4. Strategic initiatives
    • 7.2.15. Luminelle
      • 7.2.15.1. Company overview
      • 7.2.15.2. Financial performance
      • 7.2.15.3. Product benchmarking
      • 7.2.15.4. Strategic initiatives
    • 7.2.16. Meditrina, Inc. (Aveta)
      • 7.2.16.1. Company overview
      • 7.2.16.2. Financial performance
      • 7.2.16.3. Product benchmarking
      • 7.2.16.4. Strategic initiatives